The approval by the US Food and Drug Administration of an important new tuberculosis treatment must lead to its availability in countries with high levels of the drug-resistant form of the deadly disease.

Regardless of the parties or individuals responsible for the recent escalation of attacks against health workers in Pakistan, both patients and medical workers risk losing their lives while seeking or providing health care

Despite important progress in research and development (R&D) for global health over the past decade, only a small fraction of new medicines developed between 2000 and 2011 were for the treatment of neglected diseases.